Regal Rexnord
RRX
$238.19
+8.33%
Regal Rexnord Corporation is a global industrial manufacturer focused on engineering and manufacturing critical components and systems, including industrial powertrain solutions, power transmission components, electric motors, electronic controls, and air-moving products. The company operates as a diversified industrial player across three primary segments: Industrial Powertrain Solutions (its largest segment), Automation & Motion Control, and Power Efficiency Solutions, serving a wide range of end markets. The current investor narrative is centered on the company's post-merger integration and synergy realization following its transformative acquisition of Altra Industrial Motion, with a focus on margin expansion, debt reduction, and leveraging its broadened product portfolio to capitalize on industrial automation and electrification trends. Recent financial trends and analyst commentary highlight debates around the pace of organic growth and the company's ability to navigate potential macroeconomic headwinds while executing on its cost synergy targets.…
RRX
Regal Rexnord
$238.19
Investment Opinion: Should I buy RRX Today?
Rating: HOLD. The core thesis is that RRX is a fairly-valued industrial growth story where near-term execution risks and a full valuation balance strong cash generation and a positive long-term trend in automation.
The stock trades at a forward P/E of 16.3x, which is reasonable for a diversified industrial, especially one with a PEG ratio of 0.77 suggesting undervaluation on a growth-adjusted basis. Robust TTM free cash flow of $893.1M and a strong current ratio of 2.15 provide a solid financial buffer. However, the modest 4.25% Q4 revenue growth and elevated trailing P/E of 33.3x temper enthusiasm, indicating much of the near-term optimism is already priced in. The stock's 49.49% 1-year outperformance also suggests limited near-term catalysts for further multiple expansion.
The thesis would upgrade to a BUY if the forward P/E compressed below 15x on market weakness while growth expectations remain intact, or if quarterly revenue growth re-accelerates sustainably above 6%. It would downgrade to a SELL if TTM free cash flow meaningfully deteriorates, gross margins fall below 36%, or the stock breaks below key technical support at $175. Relative to its own history and growth profile, the stock appears fairly valued, not clearly overvalued or undervalued.
Sign up to view all
RRX 12-Month Price Forecast
The outlook is balanced with a slight tilt towards caution. The compelling valuation on a forward basis (P/E 16.3x, PEG 0.77) and strong cash generation are offset by the stock's rich trailing multiple and its reliance on flawless execution to bridge the gap between current modest growth and future expectations. The base case of range-bound trading is most probable. The stance would upgrade to bullish on a successful breakout above $236.35 with volume, confirming the primary uptrend has resumed. It would turn bearish if the stock breaks and sustains below the $200 psychological and technical support level, signaling a deeper correction is underway.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Regal Rexnord's 12-month outlook, with a consensus price target around $309.65 and implied upside of +30.0% versus the current price.
Average Target
$309.65
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$191 - $310
Analyst target range
Analyst coverage for Regal Rexnord is limited, with only 3 analysts providing estimates according to the provided data, which suggests this may be a mid-cap name with less widespread institutional following. The consensus sentiment, inferred from recent institutional ratings, is bullish, with firms like Barclays, Keybanc, Citigroup, Goldman Sachs, JP Morgan, and Oppenheimer maintaining 'Overweight', 'Buy', or 'Outperform' ratings as recently as March 2026. The average EPS estimate for the forward period is $15.22, with a tight range from $14.96 to $15.48. The implied upside or downside to a consensus price target cannot be calculated precisely as an average target price is not provided in the dataset. The limited number of analysts and the absence of a clear target price range in the data indicates higher uncertainty and potentially less efficient price discovery compared to heavily covered large-cap stocks. The recent rating actions show stability, with the last change being a downgrade from Jefferies to 'Hold' from 'Buy' in December 2025, while all other recent actions have been reiterations of positive ratings.
Bulls vs Bears: RRX Investment Factors
The bullish case, supported by strong free cash flow, expected earnings acceleration (forward P/E 16.3x), and positive technical momentum, currently holds stronger evidence. The bearish concerns center on a rich trailing valuation (P/E 33.3x) and modest 4.25% YoY revenue growth, which may not justify the premium. The single most important tension in the investment debate is between the market's high expectations embedded in the forward multiple and the company's ability to deliver accelerated earnings growth through successful synergy capture from the Altra acquisition. If execution falters or macro headwinds intensify, the valuation multiple is at risk of significant compression.
Bullish
- Strong Free Cash Flow Generation: The company generates robust TTM free cash flow of $893.1M, providing significant financial flexibility. This supports debt reduction, shareholder returns, and strategic investments, underpinning a healthy financial foundation.
- Earnings Growth & Margin Stability: Forward P/E of 16.3x represents a significant discount to the trailing P/E of 33.3x, signaling strong expected earnings growth. Q4 2025 gross margin of 37.5% and operating margin of 11.1% show stable, solid profitability.
- PEG Ratio Suggests Undervaluation: A PEG ratio of 0.77, based on trailing metrics, indicates the stock may be undervalued relative to its growth rate. This is a classic metric for identifying growth-at-a-reasonable-price (GARP) opportunities.
- Analyst Consensus Bullish: Recent institutional ratings from major firms (Barclays, Goldman, JP Morgan) are overwhelmingly 'Overweight' or 'Buy'. This consensus reflects confidence in the post-merger synergy execution and margin expansion story.
Bearish
- Elevated Trailing P/E Valuation: The trailing P/E of 33.3x is high for an industrial cyclical, indicating the stock is priced for perfection on current earnings. This leaves it vulnerable to multiple compression if growth disappoints.
- Modest Organic Revenue Growth: Q4 2025 revenue grew only 4.25% YoY. For a stock priced on future growth, this modest pace raises questions about the sustainability of its premium valuation and synergy realization.
- Limited Analyst Coverage: Only 3 analysts provide estimates, indicating less institutional following and potentially higher price discovery uncertainty. The lack of a clear consensus price target in the data adds to valuation opacity.
- Cyclical Sensitivity & High Beta: A beta of 1.098 confirms the stock is more volatile than the market, typical for industrials. This exposes it to amplified downside during economic slowdowns or sector rotations away from cyclicals.
RRX Technical Analysis
The stock is in a strong, sustained uptrend over the past year, with a 1-year price change of +49.49%, significantly outperforming the broader market (SPY +19.14%). As of the latest close of $219.75, the price is trading at approximately 80% of its 52-week range ($127.96 to $236.35), indicating it is positioned closer to the upper bound of its yearly trading band, which suggests positive momentum but also raises questions about near-term overextension. The stock has experienced a notable pullback from its recent highs, with a 3-month return of +19.81% and a 1-month return of +6.67%, indicating that while the longer-term trend is powerfully bullish, short-term momentum has moderated, potentially entering a consolidation phase after the sharp run-up earlier in the year. The stock's beta of 1.098 indicates it is slightly more volatile than the market, which is typical for an industrial cyclical, and its relative strength versus the SPY is positive across all measured periods, most notably a 30.35% outperformance over the past year. Key technical support is anchored at the 52-week low of $127.96, though a more relevant near-term support level is likely in the $175-$185 range where the stock consolidated in March, while immediate resistance sits at the 52-week high of $236.35; a decisive breakout above this level would signal a resumption of the primary uptrend, whereas a breakdown below the $200 psychological support could indicate a deeper correction is underway.
Beta
1.10
1.10x market volatility
Max Drawdown
-21.7%
Largest decline past year
52-Week Range
$128-$239
Price range past year
Annual Return
+64.3%
Cumulative gain past year
| Period | RRX Return | S&P 500 |
|---|---|---|
| 1m | +18.1% | -1.3% |
| 3m | +24.5% | +14.0% |
| 6m | +69.7% | +9.5% |
| 1y | +64.3% | +20.9% |
| ytd | +63.0% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RRX Fundamental Analysis
Revenue growth has been modest but positive, with the most recent quarterly revenue (Q4 2025) of $1.52 billion representing a year-over-year increase of 4.25% from the $1.46 billion reported in Q4 2024. Sequentially, revenue grew from $1.50 billion in Q3 2025, indicating stable demand. The Industrial Powertrain Solutions segment is the primary revenue driver at $1.29 billion for the period, followed by Automation and Motion Control at $883 million and Power Transmission Solutions at $783 million. The company is profitable, reporting net income of $63.5 million for Q4 2025, translating to a net margin of 4.17%. Gross margin for the quarter was a healthy 37.5%, consistent with the prior quarter's 37.0% and showing stability. Operating margin for the quarter was 11.1%, reflecting solid operational execution. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.74, indicating a manageable capital structure. The company's current ratio of 2.15 demonstrates strong short-term liquidity. Crucially, the company is generating robust free cash flow, with TTM free cash flow reported at $893.1 million, providing ample internal funding for growth initiatives, debt repayment, and shareholder returns, as evidenced by a dividend yield of approximately 1.0% and a payout ratio of 33.3%.
Quarterly Revenue
$1.5B
2025-12
Revenue YoY Growth
+0.04%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$893100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RRX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is elevated at 33.25x, while the forward PE is significantly lower at 16.26x, indicating the market is pricing in a substantial recovery and growth in earnings over the next year. This forward multiple suggests the stock is trading on future earnings expectations rather than current profitability. Compared to the broader Industrials sector, Regal Rexnord's forward PE of 16.3x appears to be in line with or at a slight premium to many diversified industrial peers, though a precise industry average is not provided in the data; the discount from the trailing multiple implies the market anticipates significant earnings expansion. Historically, the stock's own PE ratio has been volatile, ranging from deeply negative figures during periods of restructuring to highs above 147x in early 2024. The current trailing PE of 33.3x sits below the extreme highs seen in early 2024 but is above levels seen in late 2023 and early 2022, suggesting the market has priced in improved fundamentals but may not be at peak historical optimism. The PEG ratio of 0.77, based on trailing metrics, suggests the stock may be undervalued relative to its growth rate if that growth is sustainable.
PE
33.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -816x~148x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is valuation compression, given the stock's elevated trailing P/E of 33.3x, which demands flawless execution of growth and synergy targets. While the debt-to-equity ratio of 0.74 is manageable, the company's modest 4.25% YoY revenue growth in Q4 2025 creates a dependency on margin expansion and cost savings to drive the significant earnings growth implied by the forward P/E. A slowdown in industrial end-markets could pressure these targets. The net margin of 4.17%, while improved, remains relatively thin, leaving earnings sensitive to operational missteps or input cost inflation.
Market & Competitive Risks: As a cyclical industrial with a beta of 1.098, RRX is exposed to macroeconomic downturns, which could trigger a sector-wide de-rating. Trading near the top of its 52-week range (~80%) after a 49.49% yearly gain, the stock is vulnerable to profit-taking and momentum reversal. The limited analyst coverage (only 3 analysts) suggests lower liquidity and potentially higher volatility during market stress. Competitive risks include pricing pressure in its core industrial segments and the need to continuously innovate within automation and electrification trends to justify its growth premium.
Worst-Case Scenario: A severe industrial recession, combined with a failure to realize Altra merger synergies, could lead to an earnings miss and a derating of the forward multiple. In this scenario, the stock could re-test its 52-week low of $127.96, representing a potential downside of approximately -42% from the current price of $219.75. A more realistic bear-case might see the stock fall to the $175-$185 consolidation support level seen in March 2026, implying a downside of -15% to -20%. The high short ratio of 3.62 indicates a notable contingent of investors betting on such a negative outcome.
FAQ
The key risks are: 1) Valuation & Execution Risk: The high trailing P/E of 33.3x is vulnerable to compression if the company fails to deliver the accelerated earnings (implied by the forward P/E of 16.3x) needed to justify it. 2) Macroeconomic & Cyclical Risk: With a beta of 1.098, the stock is sensitive to economic downturns which could hurt demand in its industrial end markets. 3) Integration Risk: The success of the Altra merger and realization of promised synergies is critical to the investment thesis. 4) Limited Coverage Risk: Only 3 analysts cover the stock, which can lead to higher volatility and less efficient price discovery.
Our 12-month outlook presents three scenarios. The Base Case (60% probability) sees the stock trading between $200 and $236, as the company meets its ~$15.22 EPS estimate with steady execution. The Bull Case (25% probability) targets $236 to $260, driven by synergy beats and stronger revenue growth. The Bear Case (15% probability) sees a drop to $175-$200 on an earnings miss or macro slowdown. The base case is most likely, centered on the stock consolidating its gains while the company executes its plan. The key assumption is that RRX meets its forward EPS target, allowing the valuation to transition from the high trailing P/E to the more reasonable forward multiple.
RRX sends mixed valuation signals. On a trailing basis, it appears expensive with a P/E of 33.3x. However, the forward P/E of 16.3x indicates the market expects significant earnings growth, making it more reasonable. The PEG ratio of 0.77, if sustainable, suggests the stock is undervalued relative to its growth rate. Compared to many industrials, the forward multiple is likely in line or at a slight premium, justified by its strong cash flow. Overall, the stock is fairly valued, trading at a price that balances future growth potential against current execution risks.
RRX is a HOLD, not a clear buy at current levels. For investors seeking industrial exposure with a GARP profile, it presents a reasonable but not compelling opportunity. The forward P/E of 16.3x and PEG of 0.77 suggest the growth story is not excessively priced, and the strong $893.1M TTM free cash flow is a positive. However, the stock's 49.49% run-up over the past year and modest 4.25% revenue growth mean much of the near-term optimism may already be reflected in the price. It could be a good buy on a pullback towards the $185-$200 support zone for long-term investors who believe in the synergy story.
RRX is more suitable for a medium-to-long-term investment horizon (12-24 months minimum). Its cyclical nature (beta 1.098) and current position near 52-week highs make it volatile for short-term trading. The investment thesis is based on the multi-quarter process of realizing merger synergies and capitalizing on long-term industrial trends, which requires patience. The 1.0% dividend yield and 33.3% payout ratio add a minor income component supportive of a longer hold. Short-term traders face heightened risk from earnings-related volatility and potential pullbacks after the strong yearly performance.